Inhibition of gastric acid
secretion by selective and non selective anticholenergic drugs.
Poisoning and over dose.
Anti muscarinic side effects
of medications in elderly.
Epinephrine – in the treatment
of anaphylactic shock.
Treatment of preterm labor with the beta adrenergic agonist
Autonomic regulation of the
urinary bladder and sexual argans.
Heavy smoker, smoking
cessation and clonidine.
New developments in the drug
treatment of glaucoma.
Fundamentals of receptor
theory.
Use of beta-agonists and risk
of death and near death from asthma.
The effects of antihypertensive
therapy on the quality of life.
Initiation of
antihypertensive treatment during NSAIDs therapy.
Effect of antihypertensive
treatment on kidney in patient with diabetes.
Prevention of stroke by
antihypertensive drug treatment in older persons with isolated hypertension.
Clinical use of digitalis
glycosides.
Adjunctive drug therapy of
acute myocardial infarction.
The management of chronic heart
failure.
Effects of enalapril on
mortality in severe congestive heart failure.
Clinical pharmacokienetics of anxiolytics and hypnotics in the elderly.
Rebound phenomena and newer hypnotics.
Clinical use of barbiturates in neurological disorders.
Benzodiazepenes – use,abuse and consequences.
New and potential anti convulsants.
Seizure disorders in pregnancy.
Hepatic considerations in the use of anti epileptic
drugs.
The role of benzodiazepines in the management of status epilepticus.
Overcoming pharmacokienetic problems in the treatment of
parkinson’s diseases.
Drug affecting movement disorders.
Mood disorders – pharmacological prevention of
recurrences.
Side effects of anti depressant drugs.
The new generation of monoamine oxidase inhibitors.
Tricyclic antidepressant poisoning.
Treatment of depression resistant to tricyclic anti
depressants.
Fluoxetine – a serotonin-specific,second generation
anti-depressant.
Impact of non-narcotic analgesic on pain management.
Centrally acting opioid drugs.
Drug treatment of cancer pain.
Clinical pharmacology of caeffine.
Tobacco dependence.
Lipid lowering and plaque regression.
Treatment of hyperlipidemias.
Analgesic poisoning.
Mechanism of action of anti inflammatory drugs.
Renal toxicity of NSAIDs.
Methotraxate in rheumatoid arthritis.
Drug treatment of gout.
Management of hyperthyroid disease.
Anti inflammatory actions of steroids.
Clinical pharmacokienetics of prednisone &
prednisolone.
Corticosteroids and adrenal suppression.
Use of estrogen and progestins and the risk of breast
cancer in post menopausal women.
Future prospects of transdermal estrogen replacement
therapy.
Pharmacokienetcs of oral contraceptive steroids and drug
interaction.
Effect of testosterone.
Insulin pharmacokienetics.
NIDDM treatment.
Management of adult onset diabetes with sulphonylurea
failure.
Clinical features and emergencies of antibiotic
resistance during therapy.
Beta-lactam antibiotics.
Cepixitime – a new third generation cephalosporins.
Prevalence and resistance to tetracyclines.
Reduction of the ocular complications of herpes zoster ophthalmicus by oral acyclovir.
New drugs for HIV infection.
Effects of antacid on the clinical pharmacokienetics of
drugs.
The pathophysiological basis
of tardive dyskienesia.